Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sravya S Nakka"'
Autor:
Eleonora Vianello, PhD, Patricia Gonzalez-Dias, MSc, Suzanne van Veen, BSc, Carmen G Engele, BSc, Edwin Quinten, BSc, Thomas P Monath, MD, Donata Medaglini, ProfPhD, Francesco Santoro, PhD, Angela Huttner, MD, Sheri Dubey, PhD, Michael Eichberg, PhD, Francis M Ndungu, PhD, Peter G Kremsner, ProfMD, Paulin N Essone, PhD, Selidji Todagbe Agnandji, MD, Claire-Anne Siegrist, ProfMD, Helder I Nakaya, PhD, Tom H M Ottenhoff, ProfMD, Mariëlle C Haks, PhD, Selidij T Agnandij, Rafi Ahmed, Jenna Anderson, Floriane Auderset, Philip Bejon, Luisa Borgianni, Jessica Brosnahan, Annalisa Ciabattini, Olivier Engler, Mariëlle C Haks, Ali M Harandi, Donald G Heppner, Alice Gerlini, Angela Huttner, Peter G Kremsner, Donata Medaglini, Thomas P Monath, Francis M Ndungu, Patricia Njuguna, Tom H M Ottenhoff, David Pejoski, Mark Page, Gianni Pozzi, Francesco Santoro, Claire-Anne Siegrist, Sheri Dubey, Michael Eichberg, Essone P Ndong, Kabwende Lumeka, Helder I Nakaya, Patricia Gonzales Dias Carvalho, Sylvia Rothenberger, Eleonora Vianello, Sravya S Nakka, Suzanne van Veen
Publikováno v:
The Lancet Microbe, Vol 3, Iss 2, Pp e113-e123 (2022)
Summary: Background: A recombinant vesicular stomatitis virus vector expressing the Zaire Ebola virus glycoprotein (rVSVΔG-ZEBOV-GP) vaccine has been reported as safe, immunogenic, and highly protective in a ring vaccination trial. We aimed to ident
Externí odkaz:
https://doaj.org/article/9d0108ac7efd4b3a99b85d9af9182e4b
Autor:
Eleonora Vianello, Josefine Persson, Björn Andersson, Suzanne van Veen, Thomaz Lüscher Dias, Francesco Santoro, Malin Östensson, Ogonna Obudulu, Christopher Agbajogu, Sara Torkzadeh, Helder I. Nakaya, Donata Medaglini, Claire-Anne Siegrist, Tom H.M. Ottenhoff, Ali M. Harandi, Selidji Todagbe Agnandji, Rafi Ahmed, Jenna Anderson, Floriane Auderset, Philip Bejon, Luisa Borgianni, Jessica Brosnahan, Annalisa Ciabattini, Olivier Engler, Marielle C. Haks, Donald Gray Heppner, Alice Gerlini, Angela Huttner, Peter G. Kremsner, Thomas Monath, Francis Ndungu, Patricia Njuguna, David Pejoski, Mark Page, Gianni Pozzi, Sheri Dubey, Micheal J. Eichberg, Patrícia Gonzalez-Dias, Paulin Ndong Essone, Lumeka Kabwende, Peter Gottfried Kremsner, Helder Nakaya, Sravya S. Nakka, Mariëlle C. Haks, Sylvia Rothenberger
Publikováno v:
iScience, Vol 26, Iss 12, Pp 108574- (2023)
Summary: The vectored Ebola vaccine rVSVΔG-ZEBOV-GP elicits protection against Ebola Virus Disease (EVD). In a study of forty-eight healthy adult volunteers who received either the rVSVΔG-ZEBOV-GP vaccine or placebo, we profiled intracellular micro
Externí odkaz:
https://doaj.org/article/d1e7ad08e3484b79982a9a85a16c47ce
Autor:
Samuel B. Lundin, Hanna Kann, Alma Fulurija, Björn Andersson, Sravya S. Nakka, Lars-Magnus Andersson, Magnus Gisslén, Ali M. Harandi
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionThe COVID-19 pandemic illustrates the need for serology diagnostics with improved accuracy. While conventional serology based on recognition of entire proteins or subunits thereof has made significant contribution to the antibody assessme
Externí odkaz:
https://doaj.org/article/62ba31f3462c4c72bc3e8ee04e20901c
Autor:
Eleonora Vianello, Patricia Gonzalez-Dias, Suzanne van Veen, Carmen G Engele, Edwin Quinten, Thomas P Monath, Donata Medaglini, Francesco Santoro, Angela Huttner, Sheri Dubey, Michael Eichberg, Francis M Ndungu, Peter G Kremsner, Paulin N Essone, Selidji Todagbe Agnandji, Claire-Anne Siegrist, Helder I Nakaya, Tom H M Ottenhoff, Mariëlle C Haks, Selidij T Agnandij, Rafi Ahmed, Jenna Anderson, Floriane Auderset, Philip Bejon, Luisa Borgianni, Jessica Brosnahan, Annalisa Ciabattini, Olivier Engler, Ali M Harandi, Donald G Heppner, Alice Gerlini, Patricia Njuguna, David Pejoski, Mark Page, Gianni Pozzi, Essone P Ndong, Kabwende Lumeka, Patricia Gonzales Dias Carvalho, Sylvia Rothenberger, Sravya S Nakka
Publikováno v:
The Lancet Microbe, 3(2), E113-E123. ELSEVIER
The Lancet Microbe, Vol 3, Iss 2, Pp e113-e123 (2022)
The Lancet Microbe
The Lancet Microbe, Vol 3, Iss 2, Pp e113-e123 (2022)
The Lancet Microbe
Background A recombinant vesicular stomatitis virus vector expressing the Zaire Ebola virus glycoprotein (rVSV Delta G-ZEBOV-GP) vaccine has been reported as safe, immunogenic, and highly protective in a ring vaccination trial. We aimed to identify t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::097ef05ae1b1194172065293a5908379
http://hdl.handle.net/1887/3480403
http://hdl.handle.net/1887/3480403
Autor:
Wu C; The Institute of Protein Environment Affinity Surveys (PEAS Institut), Linköping, Sweden.; Maternal and Children Health Care Hospital of Zhuhai City, Zhuhai, China., Nakka S; The Institute of Protein Environment Affinity Surveys (PEAS Institut), Linköping, Sweden.; Department of Medical Sciences, Örebro University, Örebro, Sweden., Mansouri S; The Institute of Protein Environment Affinity Surveys (PEAS Institut), Linköping, Sweden., Bengtsson T; Department of Medical Sciences, Örebro University, Örebro, Sweden., Nayeri T; The Institute of Protein Environment Affinity Surveys (PEAS Institut), Linköping, Sweden., Nayeri F; The Institute of Protein Environment Affinity Surveys (PEAS Institut), Linköping, Sweden. fariba.nayeri@regionostergotland.se.; Division of Infectious Diseases, Department of Medical and Health Sciences, Linköping University, Linköping, Sweden. fariba.nayeri@regionostergotland.se.
Publikováno v:
BMC microbiology [BMC Microbiol] 2016 Sep 09; Vol. 16, pp. 209. Date of Electronic Publication: 2016 Sep 09.
Autor:
Lönn J; The Institution for Protein Environment Affinity Surveys (PEAS Institute), Linköping, Sweden., Johansson CS, Nakka S, Palm E, Bengtsson T, Nayeri F, Ravald N
Publikováno v:
Journal of periodontology [J Periodontol] 2014 Jan; Vol. 85 (1), pp. 113-22. Date of Electronic Publication: 2013 Apr 18.